203 related articles for article (PubMed ID: 37476821)
1. Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review.
Wang HM; Qiao YY; Cai BY; Tan J; Na L; Wang Y; Lu H; Tang YD
Front Vet Sci; 2023; 10():1237186. PubMed ID: 37476821
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR/Cas9 for Rapid Genome Editing of Pseudorabies Virus and Bovine Herpesvirus-1.
Yu W; Liu J; Liu Y; Forlenza M; Chen H
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400086
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Pseudorabies Virus (PRV) Expressing Firefly Luciferase Effectively Screened for CRISPR/Cas9 Single Guide RNAs and Antiviral Compounds.
Tang YD; Liu JT; Fang QQ; Wang TY; Sun MX; An TQ; Tian ZJ; Cai XH
Viruses; 2016 Mar; 8(4):90. PubMed ID: 27043610
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-based generation of a recombinant double-reporter pseudorabies virus and its characterization in vitro and in vivo.
Fu PF; Cheng X; Su BQ; Duan LF; Wang CR; Niu XR; Wang J; Yang GY; Chu BB
Vet Res; 2021 Jun; 52(1):95. PubMed ID: 34174954
[TBL] [Abstract][Full Text] [Related]
5. A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR/Cas9 system.
Xu A; Qin C; Lang Y; Wang M; Lin M; Li C; Zhang R; Tang J
Biotechnol Lett; 2015 Jun; 37(6):1265-72. PubMed ID: 25724716
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication.
Tang YD; Liu JT; Wang TY; Sun MX; Tian ZJ; Cai XH
Arch Virol; 2017 Dec; 162(12):3881-3886. PubMed ID: 28900740
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Constructed Pseudorabies Virus Mutants Reveal the Importance of UL13 in Alphaherpesvirus Escape from Genome Silencing.
Van Cleemput J; Koyuncu OO; Laval K; Engel EA; Enquist LW
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361431
[TBL] [Abstract][Full Text] [Related]
8. A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
Luo C; Wang Q; Guo R; Zhang J; Zhang J; Zhang R; Ma X; Wang P; Adam FEA; Zeshan B; Yang Z; Zhou Y; Wang X
Virus Res; 2022 Dec; 322():198937. PubMed ID: 36174845
[TBL] [Abstract][Full Text] [Related]
9. A Genome-Wide CRISPR/Cas9 Screen Reveals the Requirement of Host Sphingomyelin Synthase 1 for Infection with Pseudorabies Virus Mutant gD
Hölper JE; Grey F; Baillie JK; Regan T; Parkinson NJ; Höper D; Thamamongood T; Schwemmle M; Pannhorst K; Wendt L; Mettenleiter TC; Klupp BG
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452438
[TBL] [Abstract][Full Text] [Related]
10. Construction and immunogenicity of a gE/gI/TK-deleted PRV based on porcine pseudorabies virus variant.
Zhao Y; Wang LQ; Zheng HH; Yang YR; Liu F; Zheng LL; Jin Y; Chen HY
Mol Cell Probes; 2020 Oct; 53():101605. PubMed ID: 32464159
[TBL] [Abstract][Full Text] [Related]
11. Subculturing cells have no effect on CRISPR/Cas9-mediated cleavage of UL30 gene in pseudorabies virus.
Ren LZ; Peng ZY; Ouyang T; Liu XH; Chen XR; Ye L; Fan JW; Ouyang HS; Pang DX; Bai JY
Animal Model Exp Med; 2018 Mar; 1(1):74-77. PubMed ID: 30891550
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease.
Zhou M; Abid M; Cao S; Zhu S
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851584
[TBL] [Abstract][Full Text] [Related]
13. Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition.
Peng Z; Ouyang T; Pang D; Ma T; Chen X; Guo N; Chen F; Yuan L; Ouyang H; Ren L
Virus Res; 2016 Sep; 223():197-205. PubMed ID: 27507009
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gE/gI- and TK/gE/gI-Gene-Deleted Pseudorabies Virus Vaccines Mediated by CRISPR/Cas9 and Cre/Lox Systems.
Li J; Fang K; Rong Z; Li X; Ren X; Ma H; Chen H; Li X; Qian P
Viruses; 2020 Mar; 12(4):. PubMed ID: 32230737
[TBL] [Abstract][Full Text] [Related]
15. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
[TBL] [Abstract][Full Text] [Related]
16. An overview: CRISPR/Cas-based gene editing for viral vaccine development.
Bhujbal S; Bhujbal R; Giram P
Expert Rev Vaccines; 2022 Nov; 21(11):1581-1593. PubMed ID: 35959589
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 Genome Editing Technology: A Valuable Tool for Understanding Plant Cell Wall Biosynthesis and Function.
Zhang Y; Showalter AM
Front Plant Sci; 2020; 11():589517. PubMed ID: 33329650
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 Mediated RNase L Knockout Regulates Cellular Function of PK-15 Cells and Increases PRV Replication.
Sui C; Jiang D; Wu X; Cong X; Li F; Shang Y; Wang J; Liu S; Shan H; Qi J; Du Y
Biomed Res Int; 2019; 2019():7398208. PubMed ID: 30941371
[TBL] [Abstract][Full Text] [Related]
20. Emergence of a novel pathogenic recombinant virus from Bartha vaccine and variant pseudorabies virus in China.
Bo Z; Miao Y; Xi R; Gao X; Miao D; Chen H; Jung YS; Qian Y; Dai J
Transbound Emerg Dis; 2021 May; 68(3):1454-1464. PubMed ID: 32857916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
